Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds
CA 2532547 C · Owner: Universita Degli Studi Di Perugia · Inventors: Velardi, Andrea; Romagne, Francois
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention relates, generally to methods and compositions for , increasing the efficiency of therapeutic antibodies. Their efficiency is enhanced through the increase of the ADCC mechanism. More particularly, the invention relates to the use of a therapeutic antibody in combination with compounds that block an inhibitory receptor or stimulate an activating receptor of an NK cell in order to enhance the efficiency of the treatment with therapeutic antibodies in human subjects.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed July 23, 2004 and granted February 25, 2020. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended July 23, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by July 23, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.